TEVA SG&A Expense Growth
Teva Pharmaceutical Industries Limited American Depositary Shares · SG&A Expense Growth
TEVA SG&A Expense Growth
Latest reported7.32%period ending
TEVA FY SG&A Growth (YoY) (0.00% → 7.32%)
Latest values, visible window
High-resolution chart · PNG
TEVA sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 7.3204% | |
| 5.8319% | |
| 1.5385% | |
| -2.3526% | |
| -3.8954% | |
| -3.547% | |
| -9.682% | |
| -15.4834% | |
| -2.1586% | |
| 8.0348% | |
| -7.1091% | |
| -4.5309% | |
| 3.9476% | |
| 16.0317% | |
| 15.0535% | |
| 9.5456% | |
| 39.3469% | |
| 32.0884% | |
| 20.9288% | |
| 96.7952% | |
| 14.6877% | |
| 33.7879% | |
| 28.1004% | |
| 11.7822% | |
| 18.3943% | |
| 31.2915% | |
| 12.4476% | |
| 5.5838% | |
| 17.5418% | |
| 27.5495% | |
| 14.0625% | |
| -8.4988% | |
| 23.0694% | |
| 52.459% | |
| -20.8726% | |
| 51.1586% | |
| 9.3567% | |
| 0% | |
| 78.2353% | |
| 0% |